Table 3.
Outcome | Crude | p | Model I† | p | Model II‡ | p |
---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||
28-day in-hospital mortality | 0.51 (0.33–0.79) | 0.0024 | 0.49 (0.30–0.81) | 0.0062 | 0.87 (0.48–1.58) | 0.65 |
28-day RRT requirement | 0.99 (0.64–1.57) | 0.99 | 0.91 (0.55–1.50) | 0.70 | 1.99 (1.02–3.86) | 0.042 |
†Model I: adjusted for comorbidity (DM, HTn, CAD, or CKD); sex, weight, height, and baseline eGFR. ‡Model II: Model I plus infection or sepsis, APACHE II score, diuretic use, and AKI stage. APACHE II, Acute Physiology and Chronic Health Evaluation II; AKI, acute kidney injury; CAD, coronary artery disease; CI, confidence interval; CKD, chronic kidney disease; DM, any type of diabetes mellitus; HR, hazard ratio; HTn, hypertension; and RRT, renal replacement therapy.